MicroRNA-200a confers chemoresistance by antagonizing TP53INP1 and YAP1 in human breast cancer

por Yu, San-Jian, Yang, Liu, Hong, Qi, Kuang, Xia-Ying, Di, Gen-Hong, Shao, Zhi-Ming
Publicado 2018

KCTD12 promotes G1/S transition of breast cancer cell through activating the AKT/FOXO1 signaling

por Ye, Run‐yi, Kuang, Xia‐ying, Zeng, Hui‐juan, Shao, Nan, Lin, Ying, Wang, Shen‐ming
Publicado 2020

ID2 predicts poor prognosis in breast cancer, especially in triple-negative breast cancer, and inhibits E-cadherin expression

por Li, Kai, Yao, Ling, Chen, Li, Cao, Zhi-Gang, Yu, San-Jian, Kuang, Xia-Ying, Hu, Xin, Shao, Zhi-Ming
Publicado 2014

Downregulation of transgelin 2 promotes breast cancer metastasis by activating the reactive oxygen species/nuclear factor-κB signaling pathway

por Yang, Liu, Hong, Qi, Xu, Si-Guang, Kuang, Xia-Ying, Di, Gen-Hong, Liu, Guang-Yu, Wu, Jiong, Shao, Zhi-Ming, Yu, San-Jian
Publicado 2019

Stathmin and phospho-stathmin protein signature is associated with survival outcomes of breast cancer patients

por Kuang, Xia-Ying, Chen, Li, Zhang, Zhi-Jie, Liu, Yi-Rong, Zheng, Yi-Zi, Ling, Hong, Qiao, Feng, Li, Shan, Hu, Xin, Shao, Zhi-Ming
Publicado 2015

Androgen receptor expression predicts different clinical outcomes for breast cancer patients stratified by hormone receptor status

por Jiang, He-Sheng, Kuang, Xia-Ying, Sun, Wei-Li, Xu, Yan, Zheng, Yi-Zi, Liu, Yi-Rong, Lang, Guan-Tian, Qiao, Feng, Hu, Xin, Shao, Zhi-Ming
Publicado 2016

A recessive variant of XRCC4 predisposes to non-BRCA1/2 breast cancer in chinese women and impairs the DNA damage response via dysregulated nuclear localization

por He, Min, Hu, Xin, Chen, Li, Cao, A-Yong, Yu, Ke-Da, Shi, Ting-Yan, Kuang, Xia-Ying, Shi, Wen-Biao, Ling, Hong, Li, Shan, Qiao, Feng, Yao, Ling, Wei, Qingyi, Di, Gen-Hong, Shao, Zhi-Ming
Publicado 2014

Characterization of PIK3CA and PIK3R1 somatic mutations in Chinese breast cancer patients

por Chen, Li, Yang, Liu, Yao, Ling, Kuang, Xia-Ying, Zuo, Wen-Jia, Li, Shan, Qiao, Feng, Liu, Yi-Rong, Cao, Zhi-Gang, Zhou, Shu-Ling, Zhou, Xiao-Yan, Yang, Wen-Tao, Shi, Jin-Xiu, Huang, Wei, Hu, Xin, Shao, Zhi-Ming
Publicado 2018